Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Dorrit Bjerg Larsen has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12722056

METHOD OF TREATING POSTURAL REFLEX ABNORMALITY CAUSED BY PARKINSON'S DISEASE

IPC classification:
A61K 31/122, A61K 31/198, A61K 31/275
Agent:
Hoeger Stellrecht & Partner Patentanwälte mbB
Agent:
Dorrit Bjerg Larsen, H. Lundbeck A/S
Status:
PATENT GRANTED
EP12729555

METHOD OF ADMINISTRATION OF 4-((1R,3S)-6-CHLORO-3-PHENYL-INDAN-1-YL)-1,2,2-TRIMETHYL-PIPERAZINE AND THE SALTS THEREOF IN THE TREATMENT OF SCHIZOPHRENIA

IPC classification:
A61K 31/496, A61P 25/18
Applicant:
H. Lundbeck A/S
Agent:
Multiple attorneys, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP12740520

POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR

IPC classification:
A61K 31/4355, A61K 31/436, A61K 31/44, A61K 31/505, A61P 25/00, C07D 213/26, C07D 213/30, C07D 213/40, C07D 213/61, C07D 213/64, C07D 213/71, C07D 213/74, C07D 213/78, C07D 405/12, C07D 491/04
Applicant:
H. Lundbeck A/S
Agent:
Multiple attorneys, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP12797909

PROCESS FOR RECOVERY OF NALMEFENE HYDROCHLORIDE

IPC classification:
A61K 31/485, A61P 25/30, C07D 489/08
Applicant:
H. Lundbeck A/S
Agent:
Dorrit Bjerg Larsen, H. Lundbeck A/S
Status:
PATENT GRANTED
EP13732471

NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS

IPC classification:
A61K 31/485, A61P 25/32
Applicant:
H. Lundbeck A/S
Agent:
Dorrit Bjerg Larsen, H. Lundbeck A/S
Status:
PATENT GRANTED
EP13805330

NEW POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR

IPC classification:
A61K 31/165, C07C 233/58, C07C 233/59, C07C 233/60
Applicant:
H. Lundbeck A/S
Agent:
Dorrit Bjerg Larsen, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature